Sun, Dec 21, 2014, 11:55 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Ventrus Biosciences, Inc. Message Board

  • blehair Sep 11, 2013 12:03 PM Flag

    Buy the dips, huge volume, $5 tgt. Even analysts gave $5 n higher targets post financing.

    Reason for the delayed reaction to getting to fair value is due to financing overhang. With enough volume, that overhang loses its grip. We will be in $5s near term, but the overhang is having its way in the form of dilution and shorts relying on that dilution. Institutions will keep this stock rallying for next couple days. These results were not priced in, the 2nd trial was a lot harder to show efficacy for. Buy the dips.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
1.450.00(0.00%)Jul 11 3:59 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.